HORIZON PHARMA, INC. | 2013 | FY | 3


The following table includes selected line items from our financial statements illustrating the effect of the revision:

 

     As Reported     Adjustment     As Revised  
     (in thousands)  

Consolidated Statements of Comprehensive Loss for the Three Months Ended March 31, 2012

      

Sales discounts and allowances

     (384     (38 )     (422

Net Sales

     2,523        (38 )     2,485   

Cost of goods sold

     2,067        (38 )     2,029   

Consolidated Statements of Comprehensive Loss for the Three Months Ended June 30, 2012

      

Sales discounts and allowances

     (767     (160 )     (927

Net Sales

     3,841        (160 )     3,681   

Cost of goods sold

     2,855        (160 )     2,695   

Consolidated Statements of Comprehensive Loss for the Three Months Ended September 30, 2012

      

Sales discounts and allowances

     (790     (202 )     (992

Net Sales

     6,521        (202 )     6,319   

Cost of goods sold

     3,810        (202 )     3,608   

Consolidated Statements of Comprehensive Loss for the Three Months Ended December 31, 2012

      

Sales discounts and allowances

     (1,405     (388 )     (1,793

Net Sales

     6,747        (388 )     6,359   

Cost of goods sold

     3,931        (388 )     3,543   

Consolidated Statements of Comprehensive Loss for the Three Months Ended March 31, 2013

      

Sales discounts and allowances

     (1,527     (478 )     (2,005

Net Sales

     9,171        (478 )     8,693   

Cost of goods sold

     4,247        (478 )     3,769   

Consolidated Statements of Comprehensive Loss for the Three Months Ended June 30, 2013

      

Sales discounts and allowances

     (5,383     (1,123 )     (6,506

Net Sales

     12,254        (1,123 )     11,131   

Cost of goods sold

     3,517        (1,123 )     2,394   

Consolidated Statements of Comprehensive Loss for the Six Months Ended June 30, 2013

      

Sales discounts and allowances

     (6,910     (1,601 )     (8,511

Net Sales

     21,425        (1,601 )     19,824   

Cost of goods sold

     7,764        (1,601 )     6,163   

Consolidated Statements of Comprehensive Loss for the Three Months Ended September 30, 2013

      
      

Sales discounts and allowances

     (5,306     (2,106 )     (7,412

Net Sales

     26,218        (2,106 )     24,112   

Cost of goods sold

     5,313        (2,106 )     3,207   

Consolidated Statements of Comprehensive Loss for the Nine Months Ended September 30, 2013

      

Sales discounts and allowances

     (12,216     (3,707 )     (15,923

Net Sales

     47,643        (3,707 )     43,936   

Cost of goods sold

     13,077        (3,707     9,370   

 


us-gaap:RestatementToPriorYearIncomeTextBlock